Intervention of resistant starch 3 on type 2 diabetes mellitus and its mechanism based on urine metabonomics by liquid chromatography-tandem mass spectrometry - 18/06/20
pages | 10 |
Iconographies | 5 |
Vidéos | 0 |
Autres | 0 |
Highlights |
• | RS3 can improve the dyslipidemia, reduce the insulin resistance, and enhance insulin sensitivity to treat T2DM. |
• | Twenty nine potential biomarkers were identified by liquid chromatography-tandem mass spectrometry |
• | We speculated that the RS3 may treat T2DM by regulating the tricarboxylic acid cycle and amino acid metabolism. |
Abstract |
As a severe metabolic disease, type 2 diabetes mellitus (T2DM) has aroused increasing public attentions. Resistant starch 3 (RS3), as a starch resistant to enzymatic hydrolysis owing to its special structure, has a good effect on improving insulin resistance and reducing blood sugar in T2DM patients. However, the possible mechanisms were barely interpreted yet. In our research, we aimed to evaluate the effects and the possible mechanisms of RS3 on the treatment of T2DM. ICR mice treated with high-fat diet (HFD) for eight weeks, and then injected with streptozotocin (STZ) (100 mg/kg) to establish the T2DM. We choose the mice with the fast blood glucose (FBG) more than 11 mmol/L as T2DM. After treated for 11 weeks the relevant data was analyzed. According to the results, the FBG was dramatically reduced (p < 0.05), which also downregulated triglyceride (p < 0.01) and total cholesterol (p < 0.01). Additionally, the insulin resistance indexes were significantly reduced (p < 0.01), the homeostasis model assessment-β and insulin-sensitive index were significantly improved (p < 0.01) in RS3 group. Meanwhile, the metabolic profiles of urine were analyzed and 29 potential biomarkers were screened out, including amino acids and lipids. In conclusion, we speculated that the tricarboxylic acid cycle, amino acid metabolism and lipid metabolism played roles in the therapeutic mechanisms of RS3 on T2DM.
Le texte complet de cet article est disponible en PDF.Abbreviations : T2D, RS3, STZ, TG, CHO, Fins, ELISA, FBG, IR, ISI, OGTT, LDL-C, HDL-C, PCA, OPLS-DA, HPLC-grade, HOMA-β, LC–MS
Keywords : Resistant starch 3, Type 2 diabetic, Metformin, Metabonomic
Plan
Vol 128
Article 110350- août 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?